Adenomatous Polyps and Adenoma-Carcinoma Sequence

Adenomatous polyps are benign neoplastic growths of the colonic and rectal epithelium that are the principal recognized precursors of colorectal cancer. The adenoma-carcinoma sequence is the model describing how such polyps progress, through accumulating molecular changes, toward invasive carcinoma; together they explain why finding and removing adenomas is central to colorectal cancer prevention.

Definition

An adenomatous polyp (adenoma) is a benign neoplastic proliferation of dysplastic glandular epithelium in the colon or rectum; the adenoma-carcinoma sequence is the multistep accumulation of genetic and epigenetic alterations through which some adenomas progress to invasive carcinoma.

Scope

This topic covers what adenomatous polyps are, the histologic and molecular features associated with their progression, and the stepwise adenoma-carcinoma sequence that links them to cancer. It treats these as a reference subject in gastroenterology and oncology and does not provide individualized clinical management instructions.

Key concepts

• Tubular, tubulovillous, and villous adenomas
• Low-grade and high-grade dysplasia
• Advanced adenoma
• Polypectomy
• Interval to malignant progression
• Surveillance after polyp removal

Key theories

Adenoma-carcinoma sequence (Vogelstein-Fearon model)

Colorectal tumorigenesis proceeds through an ordered accumulation of genetic alterations, classically including activation of oncogenes and inactivation of tumor-suppressor genes, that parallels the histologic progression from normal mucosa through adenoma to carcinoma.

Mechanisms

In the classical model, normal colonic epithelium acquires an early alteration that initiates adenoma formation, after which further genetic and epigenetic changes accumulate as the lesion grows and acquires higher-grade dysplasia, eventually permitting invasion through the basement membrane. Vogelstein and colleagues described a characteristic ordering of these alterations across the spectrum of lesions, and Fearon and Vogelstein synthesized them into a multistep genetic model. Larger size, villous histology, and high-grade dysplasia mark adenomas more advanced along this pathway, although progression is variable and not every adenoma becomes cancer.

Clinical relevance

Because adenomas are the dominant precursor of colorectal cancer, their detection and removal underpin screening and surveillance programs. Long-term studies have associated colonoscopic polypectomy with reduced colorectal cancer incidence and mortality. This entry describes how that evidence is generated and is not a basis for individual diagnostic or treatment decisions.

Epidemiology

Adenomas are common, with prevalence rising with age and varying with risk factors shared with colorectal cancer. Most do not progress to cancer within a person's lifetime, but the subset with advanced features carries higher risk, which is why surveillance intervals after polypectomy are stratified by polyp characteristics in consensus recommendations.

Evidence & guidelines

The National Polyp Study and its long-term follow-up provided influential evidence linking polypectomy to lower colorectal cancer incidence and mortality, and multi-society task forces issue consensus recommendations on follow-up after polypectomy. These describe population evidence and consensus rather than directing the care of any individual.

History

The adenoma-carcinoma sequence was crystallized in the late 1980s and 1990 when molecular studies mapped a stepwise set of genetic alterations onto the histologic progression of colorectal tumors. This molecular picture, combined with clinical evidence that removing polyps prevents cancer, established adenomas as the central target of colorectal cancer prevention.

Debates

Do all colorectal cancers arise via the classic adenoma-carcinoma sequence?

An alternative serrated pathway, distinct from the classical adenomatous route, accounts for a meaningful share of colorectal cancers, prompting refinement of the single-sequence model and attention to serrated lesions in surveillance.

Key figures

• Bert Vogelstein
• Eric Fearon
• Sidney Winawer
• Ann Zauber

Seminal works

• vogelstein-1988
• fearon-vogelstein-1990
• winawer-1993

Frequently asked questions

Do all adenomatous polyps become cancer?

No. Adenomas are precursors and only a minority progress to cancer, typically over years; features such as larger size, villous histology, and high-grade dysplasia are associated with greater progression risk.

What is the adenoma-carcinoma sequence?

It is the model describing how colorectal epithelium accumulates genetic and epigenetic changes that drive progression from normal mucosa to adenoma to invasive carcinoma.